Literature DB >> 2567591

Duration of a clozapine trial in neuroleptic-resistant schizophrenia.

H Y Meltzer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567591     DOI: 10.1001/archpsyc.1989.01810070098017

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  10 in total

1.  Myths and mystifications of managed care.

Authors:  J P Docherty
Journal:  J Ment Health Adm       Date:  1990

2.  Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study.

Authors:  K H Kho; B A Blansjaar; S de Vries; D Babuskova; A H Zwinderman; D H Linszen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

Review 3.  Review: treatment of schizophrenia. State of the art.

Authors:  H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 4.  Significant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subject.

Authors:  Tongeji E Tungaraza
Journal:  Ther Adv Psychopharmacol       Date:  2016-05-31

Review 5.  Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.

Authors:  W W Fleischhacker; M Hummer
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 6.  Conventional versus novel antipsychotics: changing concepts and clinical implications.

Authors:  G Remington; S A Chong
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

7.  Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.

Authors:  Marc Ziegenbein; Georg Wittmann; Stefan Kropp
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

8.  Clinical use of clozapine in a major urban setting: one year experience.

Authors:  E W Chow; E J Collins; S E Nuttall; A S Bassett
Journal:  J Psychiatry Neurosci       Date:  1995-03       Impact factor: 6.186

9.  Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis.

Authors:  Rebecca N S Harrison; Robin M Murray; Sang Hyuck Lee; Jose Paya Cano; David Dempster; Charles J Curtis; Danai Dima; Fiona Gaughran; Gerome Breen; Simone de Jong
Journal:  Psychiatr Genet       Date:  2016-10       Impact factor: 2.458

10.  Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia.

Authors:  Herbert Y Meltzer; Daniel B Share; Karu Jayathilake; Ronald M Salomon; Myung A Lee
Journal:  J Clin Psychopharmacol       Date:  2020 May-Jun       Impact factor: 3.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.